Tencent (TCEHY) will become a top shareholder of Manus in unwinding of the Meta (META) deal, reports Nikkei
Newsquawk Staff ·
Tencent (TCEHY) will become a top shareholder of Manus in unwinding of the Meta (META) deal, reports Nikkei.
What it means
Reported unwinds of announced technology deals, with a strategic buyer stepping into the vacated position, have precedent in cases where regulatory friction or diligence issues break the original transaction and a second bidder picks up the asset or stake on revised terms. The read here runs on two tracks: for Meta, an unwound acquisition of an AI asset of this kind has historically been read as a setback in the race to bolt on agentic capability, with the more durable signal being whether the unwind was driven by antitrust exposure, by conditions in the target's home jurisdiction, or by the buyer's own volition, since each carries a different implication for future deal-making. For Tencent, building a top shareholder position rather than taking full control fits its established pattern of minority stakes across AI and consumer internet assets, a structure that limits integration risk while securing optionality and strategic alignment. Nikkei-sourced reports of this nature have generally proven reliable on Asian corporate activity, though the initial framing often precedes confirmation from the parties and the precise terms. The follow-ons are official confirmation or denial from Meta and Tencent, any regulatory dimension behind the unwind, and whether competing bidders for the asset resurface. Until terms and the reason for the original deal's collapse are clear, the read on both names is directional rather than quantifiable.
Sources
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders
- Newsquawk Daily European Opening News - 23rd October 2026
- PRE-MARKET JAPANESE AND SOUTH KOREAN STOCKS NEWS: Tech stocks in focus after the sell off in the sector stateside, while SK Hynix cancels plan to list Solidigm unit on the Nasdaq
- PRE-MARKET AUSTRALIAN STOCKS NEWS: Whitehaven Coal (WHC AT) Q1 managed run-of-mine production rose 3% Q/Q to 11.0mln tons, equity sales of produced coal fell 5% Q/Q to 6.0mln tons
- State of Rhode Island sues Meta (META) over alleged tolerance for scam advertising
Related headlines
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation1 hour ago
- [MARKET ANALYSIS] Crude benchmarks edge higher as the geopolitical environment remains tense5 hours ago
- US President Trump posts "Senator Roger Marshall of Kansas has done an incredible job in representing his Great State! Because of him....Bombardier is investing 270 MILLION DOLLARS, creating THOUSANDS of American Jobs in Kansas, Texas, and Indiana"10 hours ago
- Tesla (TSLA) has decided not to proceed with plans to produce Cybertruck for Australia and New Zealand14 hours ago
- US President Trump will deliver remarks in Florida on Friday, Georgia on Saturday and Michigan on Sunday, according to The Whiye House15 hours ago
- OpenAI trims valuation target to USD 1.25tln after previously pitching a higher price, according to FT16 hours ago
- Newsquawk Daily Asia-Pac Opening News - 23rd October 202616 hours ago
- US President Trump on Iran, says may do it a little bit further17 hours ago
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE17 hours ago
- US President Trump, on Ukraine’s Starlink (SPCX) access, says it’s a very interesting situation; won’t comment on whether he spoke to Elon Musk; bottom line is Musk put it back17 hours ago
- US President Trump invokes Section 232 on wind turbine imports18 hours ago
- US President Trump signs EO on housing costs, aiming to cut mortgage insurance premiums18 hours ago
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone19 hours ago
- US President Trump called Musk and asked him to lift Ukraine Starlink (SPCX) restrictions, WSJ reports20 hours ago
- Moderna (MRNA) downside attributed to early data leaks (link below) - UNCONFIRMED21 hours ago